Integrative Analysis of DNA Methylation and Gene Expression Profiling Data Reveals Candidate Methylation-Regulated Genes in Hepatoblastoma

References

• Bosman FT, Carneiro F, Hruban RH, Theise ND. WHO Classification of Tumours of the Digestive System. World Health Organization; 2010.
   Google Scholar
• Spector LG, Birch J. The epidemiology of hepatoblastoma. Pediatr Blood Cancer. 2012;59(5):776–779. doi:10.1002/pbc.24215
   PubMed Web of Science ®Google Scholar
• Dong R, Jia D, Xue P, et al. Genome-wide analysis of long noncoding RNA (lncRNA) expression in hepatoblastoma tissues. PLoS One. 2014;9(1):e85599. doi:10.1371/journal.pone.0085599
   PubMed Web of Science ®Google Scholar
• Baheti AD, Chapman T, Rudzinski E, Albert CM, Stanescu AL. Diagnosis, histopathologic correlation and management of hepatoblastoma: what the radiologist needs to know. Clin Imaging. 2018;52:273–279. doi:10.1016/j.clinimag.2018.08.009
   PubMed Web of Science ®Google Scholar
• Jost E, Wilop S, Herman JG, Osieka R, Galm O. Aberrant DNA methylation of the transcription factor C/EBPalpha in acute myelogenous leukemia. Leuk Res. 2009;33(3):443–449. doi:10.1016/j.leukres.2008.07.027
   PubMed Web of Science ®Google Scholar
• Galm O, Wilop S, Lüders C, et al. Clinical implications of aberrant DNA methylation patterns in acute myelogenous leukemia. Ann Hematol. 2005;84(Suppl 1):39–46. doi:10.1007/s00277-005-0005-0
   PubMed Web of Science ®Google Scholar
• Liu W, Chen S, Liu B. Diagnostic and prognostic values of serum exosomal microRNA-21 in children with hepatoblastoma: a Chinese population-based study. Pediatr Surg Int. 2016;32(11):1059–1065. doi:10.1007/s00383-016-3960-8
   PubMed Web of Science ®Google Scholar
• Bird A. DNA methylation patterns and epigenetic memory. Genes Dev. 2002;16(1):6–21. doi:10.1101/gad.947102
   PubMed Web of Science ®Google Scholar
• Wilting RH, Dannenberg JH. Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance. Drug Resist Updat. 2012;15(1–2):21–38. doi:10.1016/j.drup.2012.01.008
   PubMed Web of Science ®Google Scholar
• Huang ZH, Hu Y, Hua D, Wu YY, Song MX, Cheng ZH. Quantitative analysis of multiple methylated genes in plasma for the diagnosis and prognosis of hepatocellular carcinoma. Exp Mol Pathol. 2011;91(3):702–707. doi:10.1016/j.yexmp.2011.08.004
   PubMed Web of Science ®Google Scholar
• Lambert MP, Paliwal A, Vaissière T, et al. Aberrant DNA methylation distinguishes hepatocellular carcinoma associated with HBV and HCV infection and alcohol intake. J Hepatol. 2011;54(4):705–715. doi:10.1016/j.jhep.2010.07.027
   PubMed Web of Science ®Google Scholar
• Yang X, Gao L, Zhang S. Comparative pan-cancer DNA methylation analysis reveals cancer common and specific patterns. Brief Bioinform. 2017;18(5):761–773. doi:10.1093/bib/bbw063
   PubMed Web of Science ®Google Scholar
• Esteller M. Epigenetics in cancer. N Engl J Med. 2008;358(11):1148–1159. doi:10.1056/NEJMra072067
   PubMed Web of Science ®Google Scholar
• Robertson AG, Kim J, Al-Ahmadie H, et al. Comprehensive molecular characterization of muscle-invasive bladder cancer. Cell. 2017;171(3):540–556. e525. doi:10.1016/j.cell.2017.09.007
   PubMed Web of Science ®Google Scholar
• Chung W, Bondaruk J, Jelinek J, et al. Detection of bladder cancer using novel DNA methylation biomarkers in urine sediments. Cancer Epidemiol Biomarkers Prev. 2011;20(7):1483–1491. doi:10.1158/1055-9965.EPI-11-0067
   PubMed Web of Science ®Google Scholar
• Dudziec E, Goepel JR, Catto JW. Global epigenetic profiling in bladder cancer. Epigenomics. 2011;3(1):35–45. doi:10.2217/epi.10.71
   PubMed Web of Science ®Google Scholar
• Dulaimi E, Uzzo RG, Greenberg RE, Al-Saleem T, Cairns P. Detection of bladder cancer in urine by a tumor suppressor gene hypermethylation panel. Clin Cancer Res. 2004;10(6):1887–1893. doi:10.1158/1078-0432.CCR-03-0127
   PubMed Web of Science ®Google Scholar
• Zhu Y, Cao X, Zhang X, Chen Q, Wen L, Wang P. DNA methylation-mediated klotho silencing is an independent prognostic biomarker of head and neck squamous carcinoma. Cancer Manag Res. 2019;11:1383. doi:10.2147/CMAR.S188415
   PubMed Web of Science ®Google Scholar
• Honda S, Minato M, Suzuki H, et al. Clinical prognostic value of DNA methylation in hepatoblastoma: four novel tumor suppressor candidates. Cancer Sci. 2016;107(6):812–819. doi:10.1111/cas.12928
   PubMed Web of Science ®Google Scholar
• Sakamoto LH, De Camargo B, Cajaiba M, Soares FA, Vettore AL. MT1G hypermethylation: a potential prognostic marker for hepatoblastoma. Pediatr Res. 2010;67(4):387–393. doi:10.1203/PDR.0b013e3181d01863
   PubMed Web of Science ®Google Scholar
• Sekiguchi M, Seki M, Kawai T, et al. Integrated multiomics analysis of hepatoblastoma unravels its heterogeneity and provides novel druggable targets. NPJ Precis Oncol. 2020;4(1):1–12. doi:10.1038/s41698-020-0125-y
   PubMed Web of Science ®Google Scholar
• Carrillo-Reixach J, Torrens L, Simon-Coma M, et al. Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications. J Hepatol. 2020;73(2):328–341. doi:10.1016/j.jhep.2020.03.025
   PubMed Web of Science ®Google Scholar
• Edgar R, Lash A. 6. The Gene Expression Omnibus (GEO): a gene expression and hybridization repository. In: The NCBI Handbook [Internet]. National Center for Biotechnology Information (US); 2003.
   Google Scholar
• Rowland JM. Hepatoblastoma: assessment of criteria for histologic classification. Med Pediatr Oncol. 2002;39(5):478–483. doi:10.1002/mpo.10171
   PubMedGoogle Scholar
• Stocker JT, Ishak KG. Hepatoblastoma. In: Neoplasms of the Liver; 1987:127–136.
   Google Scholar
• Kremer N, Walther AE, Tiao GM. Management of hepatoblastoma: an update. Curr Opin Pediatr. 2014;26(3):362–369. doi:10.1097/MOP.0000000000000081
   PubMed Web of Science ®Google Scholar
• Czauderna P, Lopez-Terrada D, Hiyama E, Häberle B, Malogolowkin MH, Meyers RL. Hepatoblastoma state of the art: pathology, genetics, risk stratification, and chemotherapy. Curr Opin Pediatr. 2014;26(1):19–28. doi:10.1097/MOP.0000000000000046
   PubMed Web of Science ®Google Scholar
• McCarville MB, Roebuck DJ. Diagnosis and staging of hepatoblastoma: imaging aspects. Pediatr Blood Cancer. 2012;59(5):793–799. doi:10.1002/pbc.24221
   PubMed Web of Science ®Google Scholar
• Maibach R, Roebuck D, Brugieres L, et al. Prognostic stratification for children with hepatoblastoma: the SIOPEL experience. Eur J Cancer. 2012;48(10):1543–1549. doi:10.1016/j.ejca.2011.12.011
   PubMed Web of Science ®Google Scholar
• Aronson DC, Schnater JM, Staalman CR, et al. Predictive value of the pretreatment extent of disease system in hepatoblastoma: results from the International Society of Pediatric Oncology Liver Tumor Study Group SIOPEL-1 study. J Clin Oncol. 2005;23(6):1245–1252. doi:10.1200/JCO.2005.07.145
   PubMed Web of Science ®Google Scholar
• Long J, Chen P, Lin J, et al. DNA methylation-driven genes for constructing diagnostic, prognostic, and recurrence models for hepatocellular carcinoma. Theranostics. 2019;9(24):7251–7267. doi:10.7150/thno.31155
   PubMed Web of Science ®Google Scholar
• Bai Y, Wei C, Zhong Y, et al. Development and validation of a prognostic nomogram for gastric cancer based on DNA methylation-driven differentially expressed genes. Int J Biol Sci. 2020;16(7):1153–1165. doi:10.7150/ijbs.41587
   PubMed Web of Science ®Google Scholar
• Cui J, Wang L, Zhong W, et al. Development and validation of epigenetic signature predict survival for patients with laryngeal squamous cell carcinoma. DNA Cell Biol. 2021;40(2):247–264. doi:10.1089/dna.2020.5789
   PubMed Web of Science ®Google Scholar
• Maschietto M, Rodrigues TC, Kashiwabara AY, et al. DNA methylation landscape of hepatoblastomas reveals arrest at early stages of liver differentiation and cancer-related alterations. Oncotarget. 2016;8(58):97871–97889. doi:10.18632/oncotarget.14208
   PubMedGoogle Scholar
• Cui X, Liu B, Zheng S, Dong K, Dong R. Genome-wide analysis of DNA methylation in hepatoblastoma tissues. Oncol Lett. 2016;12(2):1529–1534. doi:10.3892/ol.2016.4789
   PubMed Web of Science ®Google Scholar
• Xu C, Sun L, Jiang C, et al. SPP1, analyzed by bioinformatics methods, promotes the metastasis in colorectal cancer by activating EMT pathway. Biomed Pharmacother. 2017;91:1167–1177. doi:10.1016/j.biopha.2017.05.056
   PubMed Web of Science ®Google Scholar
• Tu Y, Fan G, Xi H, et al. Identification of candidate aberrantly methylated and differentially expressed genes in thyroid cancer. J Cell Biochem. 2018;119(11):8797–8806. doi:10.1002/jcb.27129
   PubMed Web of Science ®Google Scholar
• Rivas MP, Aguiar TFM, Fernandes GR, et al. TET upregulation leads to 5-hydroxymethylation enrichment in hepatoblastoma. Front Genet. 2019;10:553. doi:10.3389/fgene.2019.00553
   PubMed Web of Science ®Google Scholar
• Beck A, Trippel F, Wagner A, et al. Overexpression of UHRF1 promotes silencing of tumor suppressor genes and predicts outcome in hepatoblastoma. Clin Epigenetics. 2018;10:27. doi:10.1186/s13148-018-0462-7
   PubMed Web of Science ®Google Scholar
• Tsung AJ, Guda MR, Asuthkar S, et al. Methylation regulates HEY1 expression in glioblastoma. Oncotarget. 2017;8(27):44398–44409. doi:10.18632/oncotarget.17897
   PubMedGoogle Scholar
• Park SB, Hwang KT, Chung CK, Roy D, Yoo C. Causal Bayesian gene networks associated with bone, brain and lung metastasis of breast cancer. Clin Exp Metastasis. 2020;37(6):657–674. doi:10.1007/s10585-020-10060-0
   PubMed Web of Science ®Google Scholar
• Ohnishi H, Kawamura M, Hanada R, et al. Infrequent mutations of the TP53 gene and no amplification of the MDM2 gene in hepatoblastomas. Genes Chromosomes Cancer. 1996;15(3):187–190. doi:10.1002/(SICI)1098-2264(199603)15:3<187::AID-GCC8>3.0.CO;2-Z
   PubMed Web of Science ®Google Scholar
• Woodfield SE, Shi Y, Patel RH, et al. MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastoma. Sci Rep. 2021;11(1):2967. doi:10.1038/s41598-021-82542-4
   PubMed Web of Science ®Google Scholar
• Martínez VG, Rubio C, Martínez-Fernández M, et al. BMP4 induces M2 macrophage polarization and favors tumor progression in bladder cancer. Clin Cancer Res. 2017;23(23):7388–7399. doi:10.1158/1078-0432.CCR-17-1004
   PubMed Web of Science ®Google Scholar
• Eckhardt BL, Cao Y, Redfern AD, et al. Activation of canonical BMP4-SMAD7 signaling suppresses breast cancer metastasis. Cancer Res. 2020;80(6):1304–1315. doi:10.1158/0008-5472.CAN-19-0743
   PubMed Web of Science ®Google Scholar